Claim 50% Off TipRanks Premium and Invest with Confidence
- Unlock hedge-fund level data and powerful investing tools designed to help you make smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis so your portfolio is always positioned for maximum potential
An update from Zhongzhi Pharmaceutical Holdings Limited ( (HK:3737) ) is now available.
Zhongzhi Pharmaceutical Holdings Limited has announced a change in its board of directors, effective April 10, 2025. Mr. Zhu Shangheng has been appointed as an independent non-executive director, taking over roles previously held by Mr. Wong Kam Wah, who has resigned. Mr. Zhu brings extensive legal expertise, particularly in pharmaceutical law, which could enhance the company’s governance and risk management capabilities.
More about Zhongzhi Pharmaceutical Holdings Limited
Zhongzhi Pharmaceutical Holdings Limited operates within the pharmaceutical industry, focusing on the production and distribution of pharmaceutical products. The company is listed on the Hong Kong Stock Exchange and is incorporated in the Cayman Islands.
YTD Price Performance: -9.09%
Average Trading Volume: 296,280
Technical Sentiment Signal: Strong Buy
Current Market Cap: HK$762.3M
See more data about 3737 stock on TipRanks’ Stock Analysis page.